leisure time -WSS

leisure time

author：leisure time 2025-10-02 18:50:06 - browse：8

To much of the public, the promise of telehealth is all about convenience — get the prescription you need quickly, and get it delivered right to your door. But as digital health companies build out their weight loss businesses, capitalizing on the popularity of drugs like Wegovy and Ozempic, they’re courting a very different audience: payers and employers who have a vested interest in preventing quick scripts.

Payers are reeling as they try to figure out how to sustainably cover GLP-1 receptor agonists, a class of remarkably effective but expensive obesity and type 2 diabetes drugs. So in the last six months, digital health companies including Teladoc, Found, Hello Alpha, and Calibrate have advanced enterprise products that pair virtual visits and prescriptions with lifestyle coaching. Their hope is that more and more payers and employers will offer their programs as a way to support lasting weight loss and metabolic health — or even require them if patients want their drugs reimbursed.

The competition is growing quickly. Telehealth companies once focused exclusively on consumers are now marketing to payers. Enterprise programs for chronic care management are promoting new services to support patients on obesity drugs. And companies like Noom and WeightWatchers, which have built gargantuan weight loss businesses for consumers and businesses alike, are starting to prescribe the drugs.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： How Long Island became the ‘eugenics capital of the world’

hotspot

WSS

Apellis safety probe of eye disease drug centers on injection needle

Medicare inequities exacerbate Puerto Rico’s health disparities

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

What AAP's gender

How Long Island became the ‘eugenics capital of the world’

Antivenom research: Lessons from HIV applied in search for universal antidote

focus

leisure time

focus

Cancer drug shortages should be causing more outrage

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

The cancer drug shortage isn’t new — and neither are the solutions

Medicare explains how it will choose drugs for negotiation

After affirmative action ruling, medical educators look to 'holistic review'

What do new weight loss drugs mean for bariatric surgery?

BioMarin wins approval for gene therapy to treat hemophilia A

Neuroscience startup Neumora files for IPO

United colonoscopy coverage change 'may cost lives,' doctors say

Antivenom research: Lessons from HIV applied in search for universal antidote

hotspot

How to make AI work for medicine

Neuroscience startup Neumora files for IPO

Community Health Systems hospitals under DOJ investigation

2024 GOP presidential candidates spar over abortion in debate

Appeals court upholds limits to abortion pill

Drug firms test therapies to halt Alzheimer’s before symptoms arise

entertainment

hotspot

hotspot

entertainment